Compare BLLN & ESNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLLN | ESNT |
|---|---|---|
| Founded | 2016 | 2008 |
| Country | United States | Bermuda |
| Employees | 713 | N/A |
| Industry | Medical Specialities | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 5.9B |
| IPO Year | N/A | 2013 |
| Metric | BLLN | ESNT |
|---|---|---|
| Price | $98.28 | $68.38 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 7 |
| Target Price | ★ $126.71 | $67.29 |
| AVG Volume (30 Days) | ★ 784.7K | 476.7K |
| Earning Date | 05-06-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 2.19% |
| EPS Growth | N/A | ★ 0.73 |
| EPS | N/A | ★ 3.89 |
| Revenue | N/A | ★ $1,260,935,000.00 |
| Revenue This Year | $46.29 | $1.12 |
| Revenue Next Year | $30.14 | $3.37 |
| P/E Ratio | ★ N/A | $37.76 |
| Revenue Growth | N/A | ★ 1.45 |
| 52 Week Low | $61.96 | $55.34 |
| 52 Week High | $150.44 | $70.00 |
| Indicator | BLLN | ESNT |
|---|---|---|
| Relative Strength Index (RSI) | 37.20 | 62.53 |
| Support Level | $73.46 | $59.69 |
| Resistance Level | $108.50 | N/A |
| Average True Range (ATR) | 8.11 | 1.60 |
| MACD | -5.35 | 0.01 |
| Stochastic Oscillator | 15.41 | 74.76 |
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.
Essent Group Ltd serves the housing finance industry by providing private mortgage insurance, reinsurance, risk management products, title insurance, and settlement services to mortgage lenders, borrowers, and investors to support homeownership. It provides credit protection to lenders and mortgage investors by covering a portion of the unpaid principal balance of a mortgage and certain related expenses in the event of a default. By providing capital to mitigate mortgage credit risk, the company allows lenders to make additional mortgage financing available to prospective homeowners.